Search

everythinglearnresearchcommunity

for

Search:↓

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

ILC1 cells contribute to hair loss in alopecia areata.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Vitiligo causes white skin patches and is linked to autoimmune issues.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

COVID-19 can trigger a relapsing form of hair loss, requiring long-term treatment strategies.

A 68-year-old woman with lupus and blood disorders improved after increased steroids and immunoglobulin treatment.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Hair growth phase in mice weakens certain immune responses.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

TNF-alpha inhibitors can cause various immune-related skin issues.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

IVIg treatment improved symptoms but caused permanent dark hair loss.